Bonjesta

Active Ingredient(s): Doxylamine Succinate + Pyridoxine Hydrochloride
FDA Approved: * November 7, 2016
Pharm Company: * DUCHESNAY
Category: Nausea & Vomiting

Doxylamine is a first-generation antihistamine used as a short-term sedative and hypnotic (sleep aid) or in combination formulations to provide night-time allergy and cold relief. It provides a calmative effect in preparations containing the analgesics paracetamol (acetaminophen) and codeine. It is prescribed in combination with vitamin B6 (pyridoxine) to prevent morning sickness in pregnant women. Its fetal safety rating is "A" (no evidence of risk).[4] It was first described... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Bonjesta Oral Tablet, Extended Release
NDC: 55494-120
Labeler:
Duchesnay USA, Inc.